APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Intravenous Antibodies

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Intravenous Antibodies Industry Growth and Trends Forecast to 2032

Report ID 17400422012 January 2026103 pages

Choose your research edition.

Industry ResearchIntravenous Antibodies Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Intravenous Antibodies Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Intravenous Antibodies Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intravenous Antibodies Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Intravenous Antibodies Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Intravenous Antibodies market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Intravenous Antibodies is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Intravenous Antibodies is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Intravenous Antibodies is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Intravenous Antibodies include Baxter, Sichuan Yuanda Shuyang, Shanghai RAAS, Octapharma, LFB Group, Kedrion, Hualan Bio, Grifols and CSL, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Intravenous Antibodies market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Intravenous Antibodies market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Intravenous Antibodies market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Intravenous Antibodies.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Intravenous Antibodies market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Intravenous Antibodies Market by Company

Baxter

Sichuan Yuanda Shuyang

Shanghai RAAS

Octapharma

LFB Group

Kedrion

Hualan Bio

Grifols

CSL

CNBG

CBPO

BPL

Biotest

Intravenous Antibodies Segment by Type

IgA

IgD

IgE

IgG

IgM

Intravenous Antibodies Segment by Application

Hospitals

Clinics

Others

Intravenous Antibodies Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intravenous Antibodies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intravenous Antibodies and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intravenous Antibodies.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Intravenous Antibodies manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Intravenous Antibodies in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of IgA Table 2. Major Company of IgD Table 3. Major Company of IgE Table 4. Major Company of IgG Table 5. Major Company of IgM Table 6. Global Intravenous Antibodies Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Intravenous Antibodies Sales by Type (2021-2026) & (K Units) Table 8. Global Intravenous Antibodies Sales Market Share in Volume by Type (2021-2026) Table 9. Global Intravenous Antibodies Sales by Type (2021-2026) & (US$ Million) Table 10. Global Intravenous Antibodies Sales Market Share in Value by Type (2021-2026) Table 11. Global Intravenous Antibodies Price by Type (2021-2026) & (US$/Unit) Table 12. Global Intravenous Antibodies Sales by Type (2027-2032) & (K Units) Table 13. Global Intravenous Antibodies Sales Market Share in Volume by Type (2027-2032) Table 14. Global Intravenous Antibodies Sales by Type (2027-2032) & (US$ Million) Table 15. Global Intravenous Antibodies Sales Market Share in Value by Type (2027-2032) Table 16. Global Intravenous Antibodies Price by Type (2027-2032) & (US$/Unit) Table 17. North America Intravenous Antibodies Sales by Type (2021-2026) & (K Units) Table 18. North America Intravenous Antibodies Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Intravenous Antibodies Sales by Type (2021-2026) & (K Units) Table 20. Europe Intravenous Antibodies Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Intravenous Antibodies Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Intravenous Antibodies Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Intravenous Antibodies Sales by Type (2021-2026) & (K Units) Table 24. Latin America Intravenous Antibodies Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Intravenous Antibodies Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Intravenous Antibodies Sales by Type (2021-2026) & (US$ Million) Table 27. Intravenous Antibodies Industry Trends Table 28. Intravenous Antibodies Industry Drivers Table 29. Intravenous Antibodies Industry Opportunities and Challenges Table 30. Intravenous Antibodies Industry Restraints Table 31. Global Intravenous Antibodies Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Intravenous Antibodies Revenue Market Share by Company (2021-2026) Table 33. Global Intravenous Antibodies Sales by Company (2021-2026) & (K Units) Table 34. Global Intravenous Antibodies Sales Share by Company (2021-2026) Table 35. Global Intravenous Antibodies Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Intravenous Antibodies Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Intravenous Antibodies Major Company Production Sites and Headquarters Table 38. Global Intravenous Antibodies Company, Product Type & Application Table 39. Global Intravenous Antibodies Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Intravenous Antibodies by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Intravenous Antibodies Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Intravenous Antibodies Sales by Region (2021-2026) & (K Units) Table 44. Global Intravenous Antibodies Sales Market Share in Volume by Region (2021-2026) Table 45. Global Intravenous Antibodies Sales by Region (2021-2026) & (US$ Million) Table 46. Global Intravenous Antibodies Sales Market Share in Value by Region (2021-2026) Table 47. Global Intravenous Antibodies Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Intravenous Antibodies Sales by Region (2027-2032) & (K Units) Table 49. Global Intravenous Antibodies Sales Market Share in Volume by Region (2027-2032) Table 50. Global Intravenous Antibodies Sales by Region (2027-2032) & (US$ Million) Table 51. Global Intravenous Antibodies Sales Market Share in Value by Region (2027-2032) Table 52. Global Intravenous Antibodies Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Intravenous Antibodies Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Intravenous Antibodies Sales by Application (2021-2026) & (K Units) Table 55. Global Intravenous Antibodies Sales Market Share in Volume by Application (2021-2026) Table 56. Global Intravenous Antibodies Sales by Application (2021-2026) & (US$ Million) Table 57. Global Intravenous Antibodies Sales Market Share in Value by Application (2021-2026) Table 58. Global Intravenous Antibodies Price by Application (2021-2026) & (US$/Unit) Table 59. Global Intravenous Antibodies Sales by Application (2027-2032) & (K Units) Table 60. Global Intravenous Antibodies Sales Market Share in Volume by Application (2027-2032) Table 61. Global Intravenous Antibodies Sales by Application (2027-2032) & (US$ Million) Table 62. Global Intravenous Antibodies Sales Market Share in Value by Application (2027-2032) Table 63. Global Intravenous Antibodies Price by Application (2027-2032) & (US$/Unit) Table 64. North America Intravenous Antibodies Sales by Application (2021-2026) & (K Units) Table 65. North America Intravenous Antibodies Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Intravenous Antibodies Sales by Application (2021-2026) & (K Units) Table 67. Europe Intravenous Antibodies Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Intravenous Antibodies Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Intravenous Antibodies Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Intravenous Antibodies Sales by Application (2021-2026) & (K Units) Table 71. Latin America Intravenous Antibodies Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Intravenous Antibodies Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Intravenous Antibodies Sales by Application (2021-2026) & (US$ Million) Table 74. Baxter Company Information Table 75. Baxter Business Overview Table 76. Baxter Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Baxter Intravenous Antibodies Product Portfolio Table 78. Baxter Recent Development Table 79. Sichuan Yuanda Shuyang Company Information Table 80. Sichuan Yuanda Shuyang Business Overview Table 81. Sichuan Yuanda Shuyang Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Sichuan Yuanda Shuyang Intravenous Antibodies Product Portfolio Table 83. Sichuan Yuanda Shuyang Recent Development Table 84. Shanghai RAAS Company Information Table 85. Shanghai RAAS Business Overview Table 86. Shanghai RAAS Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Shanghai RAAS Intravenous Antibodies Product Portfolio Table 88. Shanghai RAAS Recent Development Table 89. Octapharma Company Information Table 90. Octapharma Business Overview Table 91. Octapharma Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Octapharma Intravenous Antibodies Product Portfolio Table 93. Octapharma Recent Development Table 94. LFB Group Company Information Table 95. LFB Group Business Overview Table 96. LFB Group Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. LFB Group Intravenous Antibodies Product Portfolio Table 98. LFB Group Recent Development Table 99. Kedrion Company Information Table 100. Kedrion Business Overview Table 101. Kedrion Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Kedrion Intravenous Antibodies Product Portfolio Table 103. Kedrion Recent Development Table 104. Hualan Bio Company Information Table 105. Hualan Bio Business Overview Table 106. Hualan Bio Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Hualan Bio Intravenous Antibodies Product Portfolio Table 108. Hualan Bio Recent Development Table 109. Grifols Company Information Table 110. Grifols Business Overview Table 111. Grifols Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Grifols Intravenous Antibodies Product Portfolio Table 113. Grifols Recent Development Table 114. CSL Company Information Table 115. CSL Business Overview Table 116. CSL Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. CSL Intravenous Antibodies Product Portfolio Table 118. CSL Recent Development Table 119. CNBG Company Information Table 120. CNBG Business Overview Table 121. CNBG Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. CNBG Intravenous Antibodies Product Portfolio Table 123. CNBG Recent Development Table 124. CBPO Company Information Table 125. CBPO Business Overview Table 126. CBPO Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. CBPO Intravenous Antibodies Product Portfolio Table 128. CBPO Recent Development Table 129. BPL Company Information Table 130. BPL Business Overview Table 131. BPL Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. BPL Intravenous Antibodies Product Portfolio Table 133. BPL Recent Development Table 134. Biotest Company Information Table 135. Biotest Business Overview Table 136. Biotest Intravenous Antibodies Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Biotest Intravenous Antibodies Product Portfolio Table 138. Biotest Recent Development Table 139. North America Intravenous Antibodies Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 140. North America Intravenous Antibodies Sales by Country (2021-2026) & (K Units) Table 141. North America Intravenous Antibodies Sales Market Share by Country (2021-2026) Table 142. North America Intravenous Antibodies Sales Forecast by Country (2027-2032) & (K Units) Table 143. North America Intravenous Antibodies Sales Market Share Forecast by Country (2027-2032) Table 144. North America Intravenous Antibodies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. North America Intravenous Antibodies Market Size by Country (2021-2026) & (US$ Million) Table 146. North America Intravenous Antibodies Market Share by Country (2021-2026) Table 147. North America Intravenous Antibodies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. North America Intravenous Antibodies Market Share Forecast by Country (2027-2032) Table 149. Europe Intravenous Antibodies Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 150. Europe Intravenous Antibodies Sales by Country (2021-2026) & (K Units) Table 151. Europe Intravenous Antibodies Sales Market Share by Country (2021-2026) Table 152. Europe Intravenous Antibodies Sales Forecast by Country (2027-2032) & (K Units) Table 153. Europe Intravenous Antibodies Sales Market Share Forecast by Country (2027-2032) Table 154. Europe Intravenous Antibodies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Europe Intravenous Antibodies Market Size by Country (2021-2026) & (US$ Million) Table 156. Europe Intravenous Antibodies Market Share by Country (2021-2026) Table 157. Europe Intravenous Antibodies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Europe Intravenous Antibodies Market Share Forecast by Country (2027-2032) Table 159. Asia-Pacific Intravenous Antibodies Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 160. Asia-Pacific Intravenous Antibodies Sales by Country (2021-2026) & (K Units) Table 161. Asia-Pacific Intravenous Antibodies Sales Market Share by Country (2021-2026) Table 162. Asia-Pacific Intravenous Antibodies Sales Forecast by Country (2027-2032) & (K Units) Table 163. Asia-Pacific Intravenous Antibodies Sales Market Share Forecast by Country (2027-2032) Table 164. Asia-Pacific Intravenous Antibodies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Asia-Pacific Intravenous Antibodies Market Size by Country (2021-2026) & (US$ Million) Table 166. Asia-Pacific Intravenous Antibodies Market Share by Country (2021-2026) Table 167. Asia-Pacific Intravenous Antibodies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Asia-Pacific Intravenous Antibodies Market Share Forecast by Country (2027-2032) Table 169. Latin America Intravenous Antibodies Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 170. Latin America Intravenous Antibodies Sales by Country (2021-2026) & (K Units) Table 171. Latin America Intravenous Antibodies Sales Market Share by Country (2021-2026) Table 172. Latin America Intravenous Antibodies Sales Forecast by Country (2027-2032) & (K Units) Table 173. Latin America Intravenous Antibodies Sales Market Share Forecast by Country (2027-2032) Table 174. Latin America Intravenous Antibodies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. Latin America Intravenous Antibodies Market Size by Country (2021-2026) & (US$ Million) Table 176. Latin America Intravenous Antibodies Market Share by Country (2021-2026) Table 177. Latin America Intravenous Antibodies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. Latin America Intravenous Antibodies Market Share Forecast by Country (2027-2032) Table 179. Middle East and Africa Intravenous Antibodies Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 180. Middle East and Africa Intravenous Antibodies Sales by Country (2021-2026) & (K Units) Table 181. Middle East and Africa Intravenous Antibodies Sales Market Share by Country (2021-2026) Table 182. Middle East and Africa Intravenous Antibodies Sales Forecast by Country (2027-2032) & (K Units) Table 183. Middle East and Africa Intravenous Antibodies Sales Market Share Forecast by Country (2027-2032) Table 184. Middle East and Africa Intravenous Antibodies Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 185. Middle East and Africa Intravenous Antibodies Market Size by Country (2021-2026) & (US$ Million) Table 186. Middle East and Africa Intravenous Antibodies Market Share by Country (2021-2026) Table 187. Middle East and Africa Intravenous Antibodies Market Size Forecast by Country (2027-2032) & (US$ Million) Table 188. Middle East and Africa Intravenous Antibodies Market Share Forecast by Country (2027-2032) Table 189. Key Raw Materials Table 190. Raw Materials Key Suppliers Table 191. Intravenous Antibodies Distributors List Table 192. Intravenous Antibodies Customers List Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Intravenous Antibodies Image Figure 2. Global Intravenous Antibodies Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intravenous Antibodies Market Size (2021-2032) & (US$ Million) Figure 4. Global Intravenous Antibodies Sales (2021-2032) & (K Units) Figure 5. IgA Image Figure 6. Global IgA Sales YoY Growth (2021-2032) & (K Units) Figure 7. IgD Image Figure 8. Global IgD Sales YoY Growth (2021-2032) & (K Units) Figure 9. IgE Image Figure 10. Global IgE Sales YoY Growth (2021-2032) & (K Units) Figure 11. IgG Image Figure 12. Global IgG Sales YoY Growth (2021-2032) & (K Units) Figure 13. IgM Image Figure 14. Global IgM Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Intravenous Antibodies Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Intravenous Antibodies Market Share by Type 2025 VS 2032 Figure 17. North America Intravenous Antibodies Sales Market Share in Volume by Type in 2025 Figure 18. North America Intravenous Antibodies Sales Market Share in Value by Type in 2025 Figure 19. Europe Intravenous Antibodies Sales Market Share in Volume by Type in 2025 Figure 20. Europe Intravenous Antibodies Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Intravenous Antibodies Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Intravenous Antibodies Sales Market Share in Value by Type in 2025 Figure 23. Latin America Intravenous Antibodies Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Intravenous Antibodies Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Intravenous Antibodies Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Intravenous Antibodies Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Intravenous Antibodies Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Hospitals Image Figure 30. Global Hospitals Sales YoY Growth (2021-2032) & (K Units) Figure 31. Clinics Image Figure 32. Global Clinics Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Intravenous Antibodies Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Intravenous Antibodies Market Share by Application 2025 VS 2032 Figure 37. North America Intravenous Antibodies Sales Market Share in Volume by Application in 2025 Figure 38. North America Intravenous Antibodies Sales Market Share in Value by Application in 2025 Figure 39. Europe Intravenous Antibodies Sales Market Share in Volume by Application in 2025 Figure 40. Europe Intravenous Antibodies Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Intravenous Antibodies Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Intravenous Antibodies Sales Market Share in Value by Application in 2025 Figure 43. Latin America Intravenous Antibodies Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Intravenous Antibodies Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Intravenous Antibodies Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Intravenous Antibodies Sales Market Share in Value by Application in 2025 Figure 47. North America Intravenous Antibodies Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Intravenous Antibodies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Intravenous Antibodies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Intravenous Antibodies Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Intravenous Antibodies Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Intravenous Antibodies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Intravenous Antibodies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Intravenous Antibodies Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Intravenous Antibodies Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Intravenous Antibodies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Intravenous Antibodies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Intravenous Antibodies Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Intravenous Antibodies Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Intravenous Antibodies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Intravenous Antibodies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Intravenous Antibodies Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Intravenous Antibodies Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Intravenous Antibodies Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Intravenous Antibodies Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Intravenous Antibodies Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Intravenous Antibodies Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Intravenous Antibodies Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • IgA
  • IgD
  • IgE
  • IgG
  • IgM
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Baxter
  • Sichuan Yuanda Shuyang
  • Shanghai RAAS
  • Octapharma
  • LFB Group
  • Kedrion
  • Hualan Bio
  • Grifols
  • CSL
  • CNBG
  • CBPO
  • BPL
  • Biotest

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Intravenous Antibodies Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Intravenous Antibodies Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Intravenous Antibodies Market by Type
  6. 1.3.1 IgA
  7. 1.3.2 IgD
  8. 1.3.3 IgE
  9. 1.3.4 IgG
  10. 1.3.5 IgM
  11. 1.4 Global Intravenous Antibodies Market Size by Type
  12. 1.4.1 Global Intravenous Antibodies Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Intravenous Antibodies Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Intravenous Antibodies Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Intravenous Antibodies Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Intravenous Antibodies Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Intravenous Antibodies Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Intravenous Antibodies Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Intravenous Antibodies Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Intravenous Antibodies Industry Trends
  2. 2.2 Intravenous Antibodies Industry Drivers
  3. 2.3 Intravenous Antibodies Industry Opportunities and Challenges
  4. 2.4 Intravenous Antibodies Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Intravenous Antibodies Revenue (2021-2026)
  2. 3.2 Global Top Players by Intravenous Antibodies Sales (2021-2026)
  3. 3.3 Global Top Players by Intravenous Antibodies Price (2021-2026)
  4. 3.4 Global Intravenous Antibodies Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Intravenous Antibodies Major Company Production Sites & Headquarters
  6. 3.6 Global Intravenous Antibodies Company, Product Type & Application
  7. 3.7 Global Intravenous Antibodies Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Intravenous Antibodies Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Intravenous Antibodies Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Intravenous Antibodies Tier 1, Tier 2, and Tier 3
4 Intravenous Antibodies Regional Status and Outlook
  1. 4.1 Global Intravenous Antibodies Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Intravenous Antibodies Historic Market Size by Region
  3. 4.2.1 Global Intravenous Antibodies Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Intravenous Antibodies Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Intravenous Antibodies Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Intravenous Antibodies Forecasted Market Size by Region
  7. 4.3.1 Global Intravenous Antibodies Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Intravenous Antibodies Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Intravenous Antibodies Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Intravenous Antibodies by Application
  1. 5.1 Intravenous Antibodies Market by Application
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Intravenous Antibodies Market Size by Application
  6. 5.2.1 Global Intravenous Antibodies Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Intravenous Antibodies Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Intravenous Antibodies Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Intravenous Antibodies Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Intravenous Antibodies Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Intravenous Antibodies Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Intravenous Antibodies Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Intravenous Antibodies Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Baxter
  2. 6.1.1 Baxter Company Information
  3. 6.1.2 Baxter Business Overview
  4. 6.1.3 Baxter Intravenous Antibodies Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Baxter Intravenous Antibodies Product Portfolio
  6. 6.1.5 Baxter Recent Developments
  7. 6.2 Sichuan Yuanda Shuyang
  8. 6.2.1 Sichuan Yuanda Shuyang Company Information
  9. 6.2.2 Sichuan Yuanda Shuyang Business Overview
  10. 6.2.3 Sichuan Yuanda Shuyang Intravenous Antibodies Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sichuan Yuanda Shuyang Intravenous Antibodies Product Portfolio
  12. 6.2.5 Sichuan Yuanda Shuyang Recent Developments
  13. 6.3 Shanghai RAAS
  14. 6.3.1 Shanghai RAAS Company Information
  15. 6.3.2 Shanghai RAAS Business Overview
  16. 6.3.3 Shanghai RAAS Intravenous Antibodies Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Shanghai RAAS Intravenous Antibodies Product Portfolio
  18. 6.3.5 Shanghai RAAS Recent Developments
  19. 6.4 Octapharma
  20. 6.4.1 Octapharma Company Information
  21. 6.4.2 Octapharma Business Overview
  22. 6.4.3 Octapharma Intravenous Antibodies Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Octapharma Intravenous Antibodies Product Portfolio
  24. 6.4.5 Octapharma Recent Developments
  25. 6.5 LFB Group
  26. 6.5.1 LFB Group Company Information
  27. 6.5.2 LFB Group Business Overview
  28. 6.5.3 LFB Group Intravenous Antibodies Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 LFB Group Intravenous Antibodies Product Portfolio
  30. 6.5.5 LFB Group Recent Developments
  31. 6.6 Kedrion
  32. 6.6.1 Kedrion Company Information
  33. 6.6.2 Kedrion Business Overview
  34. 6.6.3 Kedrion Intravenous Antibodies Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Kedrion Intravenous Antibodies Product Portfolio
  36. 6.6.5 Kedrion Recent Developments
  37. 6.7 Hualan Bio
  38. 6.7.1 Hualan Bio Company Information
  39. 6.7.2 Hualan Bio Business Overview
  40. 6.7.3 Hualan Bio Intravenous Antibodies Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Hualan Bio Intravenous Antibodies Product Portfolio
  42. 6.7.5 Hualan Bio Recent Developments
  43. 6.8 Grifols
  44. 6.8.1 Grifols Company Information
  45. 6.8.2 Grifols Business Overview
  46. 6.8.3 Grifols Intravenous Antibodies Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Grifols Intravenous Antibodies Product Portfolio
  48. 6.8.5 Grifols Recent Developments
  49. 6.9 CSL
  50. 6.9.1 CSL Company Information
  51. 6.9.2 CSL Business Overview
  52. 6.9.3 CSL Intravenous Antibodies Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 CSL Intravenous Antibodies Product Portfolio
  54. 6.9.5 CSL Recent Developments
  55. 6.10 CNBG
  56. 6.10.1 CNBG Company Information
  57. 6.10.2 CNBG Business Overview
  58. 6.10.3 CNBG Intravenous Antibodies Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 CNBG Intravenous Antibodies Product Portfolio
  60. 6.10.5 CNBG Recent Developments
  61. 6.11 CBPO
  62. 6.11.1 CBPO Company Information
  63. 6.11.2 CBPO Business Overview
  64. 6.11.3 CBPO Intravenous Antibodies Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 CBPO Intravenous Antibodies Product Portfolio
  66. 6.11.5 CBPO Recent Developments
  67. 6.12 BPL
  68. 6.12.1 BPL Company Information
  69. 6.12.2 BPL Business Overview
  70. 6.12.3 BPL Intravenous Antibodies Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 BPL Intravenous Antibodies Product Portfolio
  72. 6.12.5 BPL Recent Developments
  73. 6.13 Biotest
  74. 6.13.1 Biotest Company Information
  75. 6.13.2 Biotest Business Overview
  76. 6.13.3 Biotest Intravenous Antibodies Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Biotest Intravenous Antibodies Product Portfolio
  78. 6.13.5 Biotest Recent Developments
7 North America by Country
  1. 7.1 North America Intravenous Antibodies Sales by Country
  2. 7.1.1 North America Intravenous Antibodies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Intravenous Antibodies Sales by Country (2021-2026)
  4. 7.1.3 North America Intravenous Antibodies Sales Forecast by Country (2027-2032)
  5. 7.2 North America Intravenous Antibodies Market Size by Country
  6. 7.2.1 North America Intravenous Antibodies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Intravenous Antibodies Market Size by Country (2021-2026)
  8. 7.2.3 North America Intravenous Antibodies Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Intravenous Antibodies Sales by Country
  2. 8.1.1 Europe Intravenous Antibodies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Intravenous Antibodies Sales by Country (2021-2026)
  4. 8.1.3 Europe Intravenous Antibodies Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Intravenous Antibodies Market Size by Country
  6. 8.2.1 Europe Intravenous Antibodies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Intravenous Antibodies Market Size by Country (2021-2026)
  8. 8.2.3 Europe Intravenous Antibodies Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Intravenous Antibodies Sales by Country
  2. 9.1.1 Asia-Pacific Intravenous Antibodies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Intravenous Antibodies Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Intravenous Antibodies Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Intravenous Antibodies Market Size by Country
  6. 9.2.1 Asia-Pacific Intravenous Antibodies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Intravenous Antibodies Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Intravenous Antibodies Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Intravenous Antibodies Sales by Country
  2. 10.1.1 South America Intravenous Antibodies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Intravenous Antibodies Sales by Country (2021-2026)
  4. 10.1.3 South America Intravenous Antibodies Sales Forecast by Country (2027-2032)
  5. 10.2 South America Intravenous Antibodies Market Size by Country
  6. 10.2.1 South America Intravenous Antibodies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Intravenous Antibodies Market Size by Country (2021-2026)
  8. 10.2.3 South America Intravenous Antibodies Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Intravenous Antibodies Sales by Country
  2. 11.1.1 Middle East and Africa Intravenous Antibodies Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Intravenous Antibodies Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Intravenous Antibodies Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Intravenous Antibodies Market Size by Country
  6. 11.2.1 Middle East and Africa Intravenous Antibodies Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Intravenous Antibodies Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Intravenous Antibodies Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Intravenous Antibodies Value Chain Analysis
  2. 12.1.1 Intravenous Antibodies Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Intravenous Antibodies Production Mode & Process
  7. 12.2 Intravenous Antibodies Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Intravenous Antibodies Distributors
  10. 12.2.3 Intravenous Antibodies Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst